Citigroup Initiates Coverage on Astera Labs (NASDAQ:ALAB)

Equities research analysts at Citigroup started coverage on shares of Astera Labs (NASDAQ:ALAB) in a research note issued on Thursday, Marketbeat reports. The firm set a “buy” rating and a $200.00 price target on the stock. Citigroup’s target price indicates a potential upside of 70.74% from the company’s previous close.

Other analysts have also issued research reports about the stock. Barclays set a $165.00 target price on shares of Astera Labs in a research report on Thursday, January 15th. Loop Capital initiated coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Northland Securities raised their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research note on Tuesday, December 9th. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Royal Bank Of Canada began coverage on Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price for the company. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $199.44.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $117.14 on Thursday. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market capitalization of $20.06 billion, a price-to-earnings ratio of 96.02, a price-to-earnings-growth ratio of 2.31 and a beta of 1.78. The business’s 50 day moving average price is $131.56 and its 200-day moving average price is $159.64.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts expect that Astera Labs will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 157,500 shares of the stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00. Following the completion of the sale, the chief executive officer directly owned 4,531,732 shares in the company, valued at $596,285,296.56. This represents a 3.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jack R. Lazar sold 2,500 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $130.00, for a total transaction of $325,000.00. Following the transaction, the director owned 84,851 shares in the company, valued at $11,030,630. The trade was a 2.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 577,292 shares of company stock valued at $69,495,249. Corporate insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada increased its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC boosted its stake in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its stake in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares during the last quarter. Cetera Investment Advisers grew its holdings in Astera Labs by 167.1% in the 2nd quarter. Cetera Investment Advisers now owns 9,131 shares of the company’s stock valued at $826,000 after buying an additional 5,712 shares in the last quarter. Finally, American Century Companies Inc. grew its holdings in Astera Labs by 383.4% in the 2nd quarter. American Century Companies Inc. now owns 32,791 shares of the company’s stock valued at $2,965,000 after buying an additional 26,008 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
• Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
• Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
• Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
• Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
• Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.